James Lillard to Mutation
This is a "connection" page, showing publications James Lillard has written about Mutation.
Connection Strength
0.166
-
Griffen TL, Hoff FW, Qiu Y, Lillard JW, Ferrajoli A, Thompson P, Toro E, Ruiz K, Burger J, Wierda W, Kornblau SM. Proteomic profiling based classification of CLL provides prognostication for modern therapy and identifies novel therapeutic targets. Blood Cancer J. 2022 03 17; 12(3):43.
Score: 0.038
-
van Dijk AD, Griffen TL, Qiu YH, Hoff FW, Toro E, Ruiz K, Ruvolo PP, Lillard JW, de Bont ESJM, Burger JA, Wierda W, Kornblau SM. RPPA-based proteomics recognizes distinct epigenetic signatures in chronic lymphocytic leukemia with clinical consequences. Leukemia. 2022 03; 36(3):712-722.
Score: 0.037
-
LillardJr JW, Bearden SW, Fetherston JD, Perry RD. The haemin storage (Hms+) phenotype of Yersinia pestis is not essential for the pathogenesis of bubonic plague in mammals. Microbiology (Reading). 1999 Jan; 145 ( Pt 1):197-209.
Score: 0.031
-
Lillard JW, Fetherston JD, Pedersen L, Pendrak ML, Perry RD. Sequence and genetic analysis of the hemin storage (hms) system of Yersinia pestis. Gene. 1997 Jul 01; 193(1):13-21.
Score: 0.028
-
Singh SK, Lillard JW, Singh R. Molecular basis for prostate cancer racial disparities. Front Biosci (Landmark Ed). 2017 01 01; 22(3):428-450.
Score: 0.027
-
Fetherston JD, Lillard JW, Perry RD. Analysis of the pesticin receptor from Yersinia pestis: role in iron-deficient growth and possible regulation by its siderophore. J Bacteriol. 1995 Apr; 177(7):1824-33.
Score: 0.006